Dividend-adjusted total return · Nov 21, 2006 – Nov 3, 2026XLV
| Returns | 1D | 1M | 3M | YTD | 1Y | 3Y | 5Y | MAX |
|---|---|---|---|---|---|---|---|---|
| Total return | −0.3% | +9.9% | +12.5% | +20.4% | +29.7% | +57.1% | +50.7% | +685.1% |
| Peer average | +0.6% | +4.0% | +6.1% | +21.0% | +29.0% | +81.2% | +28.9% | — |
| S&P 500 · VOO | +0.3% | −2.6% | −1.7% | +11.5% | +11.9% | +90.9% | +77.5% | — |
Key Statistics
Open all fund facts →- AUM
- $49.1B
- Expense ratio
- 0.08%
- Distribution yield
- 1.4%
- NAV
- $184.59
- Volume
- 11.3M
- Avg. volume 30D
- 9.3M
- High today
- $185.72
- Low today
- $183.57
- Previous close
- $184.60
- 52-week high
- $187.99
- 52-week low
- $141.97
- Our risk indicator
- 4/5
XLV in One Breath
XLV Among Health Care ETFs
YTDEnd-of-day Nov 4, 2026 · 33 Health care ETFs by YTD
$10,000 in XLV
5Y$10,000 in XLV became
$15,068
In the S&P 500 (VOO)
$17,749
Total return, dividends in · Oct 26, 2021 – Nov 3, 2026 · S&P 500 uses VOO
XLV’s Top Holdings
TodayLLYEli Lilly +16.5%JNJ9.9%ABBV7.7%UNH5.5%MRK5.4%TMO3.9%AMGN3.7%GILD3.1%ABT2.7%PFE2.6%ISRG2.4%DHR2.2%VRTX2.1%BMY1.9%MDT1.8%CVS1.7%MCK1.7%SYK1.6%ELV1.4%MRNAREGNCI39 more
Drug Manufacturers - GeneralMedical - DiagnosticsMedical - Healthcare PlansMedical - DevicesBiotechnologyMedical - InstrumentsOther
SPDR XLV · 61 holdings · tile size = share of the fund · as of Nov 1, 2026
What XLV Holds
TodayDrug Manufacturers - General51.3%
LLY 16.5 · JNJ 9.9 · ABBV 7.7 · MRK 5.4 · AMGN 3.7 · GILD 3.1 · PFE 2.6
Medical - Diagnostics & Research11.6%
TMO 3.9 · DHR 2.2 · A · WAT · IDXX · IQV · ILMN
Medical - Healthcare Plans11.1%
UNH 5.5 · CVS 1.7 · ELV 1.4 · CI 1.2 · HUM · CNC
Medical - Devices9.4%
ABT 2.7 · MDT 1.8 · SYK 1.6 · BSX · EW · GEHC · DXCM
Biotechnology5.0%
VRTX 2.1 · MRNA 1.2 · REGN 1.2 · INCY · TECH
Medical - Instruments & Supplies4.7%
ISRG 2.4 · BDX · RMD · WST · BAX · SOLV · COO
Medical - Distribution3.7%
MCK 1.7 · COR · CAH · HSIC
SPDR XLV · share of the fund by industry · as of Nov 1, 2026
Eli’s Share of XLV
Today16.5%
$165 of every $1,000 in XLV is Eli
Eli held by XLV
$8.1B
SPDR XLV · each square = $10 of $1,000 · as of Nov 1, 2026
XLV’s Share of Health Care ETFs
Today45.0%
of the $109B in 39 Health care ETFs
$49.1B45.0%
$19.1B17.5%
$10.5B9.6%
$30.3B27.8%
Health care ETF AUM · Nov 4, 2026
XLV Fee per $100 vs Peers
TodayExpense ratio · Health care peers · Nov 4, 2026
Inside XLV
61 holdings · as of Nov 1, 2026XLV
State Street Health Care Select Sector SPDR ETF
TodayDrug Manufacturers - General51.3%LLYELI Lilly +16.5%JNJ9.9%ABBV7.7%MRK5.4%AMGN3.7%GILD3.1%PFEBMYBIIBMedical - Diagnostics11.6%TMO3.9%DHRAWATIDXXIQVILMNMTDLHDGXMedical - Healthcare Plans11.1%UNH5.5%CVSELVCIHUMCNCMedical - Devices9.4%ABTMDTSYKBSXEWDXCMZBHBiotechnology5.0%VRTX2.1%MRNAREGNMedical - Instruments4.7%ISRGBDXRMDWSTMedical - Distribution3.7%MCKCORCAHHCAZTSVEEVSTE
Drug Manufacturers - General51.3%LLY16.5%JNJ9.9%ABBV7.7%MRK5.4%AMGN3.7%GILD3 moreMedical - Diagnostics11.6%TMODHRAWATIDXX6 moreMedical - Healthcare Plans11.1%UNH5.5%CVSELVCIHUMMedical - Devices9.4%ABTMDTSYKBiotechnology5.0%VRTXMRNAREGNMedical - Instruments4.7%ISRGBDXMedical - Distribution3.7%MCKCORCAHHCAZTSVTRS
| # | Ticker | Company | Weight ▼ |
|---|---|---|---|
| 1 | LLY | ELI Lilly + | 16.46% |
| 2 | JNJ | Johnson + Johnson | 9.93% |
| 3 | ABBV | Abbvie | 7.70% |
| 4 | UNH | Unitedhealth Group | 5.52% |
| 5 | MRK | Merck + | 5.41% |
| 6 | TMO | Thermo Fisher Scientific | 3.93% |
| 7 | AMGN | Amgen | 3.73% |
| 8 | GILD | Gilead Sciences | 3.08% |
| 9 | ABT | Abbott Laboratories | 2.71% |
| 10 | PFE | Pfizer | 2.56% |
Drug Manufacturers - GeneralMedical - DiagnosticsMedical - Healthcare PlansMedical - DevicesBiotechnologyMedical - InstrumentsMedical - DistributionMedical - Care FacilitiesDrug Manufacturers - SpecialtySoftware - ApplicationMedical - SpecialtiesOther
SPDR XLV · current holdings by weight · as of Nov 1, 2026 · each tile is one holding · top 20 = 79.0%
How It Compares
XLV
State Street Health Care Select Sector SPDR ETF’s Peers
YTDHealth care peers · YTD and past-year returns · as of Nov 4, 2026 · sorted by AUM
Head to Head
Put XLV head to head with VHT →VHT vs XLV
YTDYear to date
XLV wins+0.7 pts
Past year
XLV wins+1.6 pts
Fee
XLV winslower fee
Yield
Level
AUM
XLV2.6× more
3–0XLV wins
Vanguard VHT and SPDR XLV · year-to-date · as of Nov 4, 2026 · AUM not scored
XLV vs VOO
YTDXLV · Health Care Select Sector SPDR
+20.4%
VOO · S&P 500
+11.5%
Gap
8.8 pts
SPDR XLV and Vanguard VOO · YTD total return · as of Nov 4, 2026
XLV vs Its Peer Average
YTDXLVAvsBPeer average
1D−0.3%+0.6%
1M+9.9%+4.0%
3M+12.5%+6.1%
YTD+20.4%+21.0%
1Y+29.7%+29.0%
3Y+57.1%+81.2%
5Y+50.7%+28.9%
4–3XLV wins
38 Health care peers · each row scaled to its leader
The Details
XLV
Risk
1Y4/5our risk indicator
CalmerBumpier
Volatility · 1Y16.38%
Deepest drop · 1Y−10.5%
Lowest point · 5Y−8.4%
52-week range
$184.02
$141.97−2.1% from the high$187.99
SPDR XLV · past-year price moves · as of Nov 4, 2026
XLV
Fund Facts
Today1998launched Dec 16
Tracks[…]
Exchange · CUSIPAMEX · 81369Y209
StructureETF
Leverage1x
Cost on $10,000$8 a year
Go deeper
SPDR XLV · fund facts · as of Nov 4, 2026
XLV
Payouts by Year
13Y$0.64per share, Sep 2026
Distribution yield1.4%
PaidEvery quarter
Latest ex-date · paidSep 21 · Sep 23, 2026
12 payouts added up$7.26 a share
SPDR XLV · distributions by ex-date · 2014–2026
All Fund FactsDocuments · trading · fees · every payout
Prospectus & Documents
SEC reported portfolio · 2026-06-30 ↗SEC reported portfolio · 2026-03-31 ↗SEC reported portfolio · 2025-12-31 ↗summary prospectus · SEC 497K ↗SEC reported portfolio · 2025-09-30 ↗summary prospectus · SEC 497K ↗SEC reported portfolio · 2025-06-30 ↗SEC reported portfolio · 2025-03-31 ↗SEC reported portfolio · 2024-12-31 ↗summary prospectus · SEC 497K ↗SEC reported portfolio · 2024-09-30 ↗SEC reported portfolio · 2024-06-30 ↗SEC reported portfolio · 2024-03-31 ↗summary prospectus · SEC 497K ↗SEC reported portfolio · 2023-12-31 ↗summary prospectus · SEC 497K ↗SEC reported portfolio · 2023-09-30 ↗SEC reported portfolio · 2023-06-30 ↗SEC reported portfolio · 2023-03-31 ↗SEC reported portfolio · 2022-12-31 ↗summary prospectus · SEC 497K ↗SEC reported portfolio · 2022-09-30 ↗summary prospectus · SEC 497K ↗SEC reported portfolio · 2022-06-30 ↗SEC reported portfolio · 2022-03-31 ↗SEC reported portfolio · 2021-12-31 ↗summary prospectus · SEC 497K ↗SEC reported portfolio · 2021-09-30 ↗SEC reported portfolio · 2021-06-30 ↗SEC reported portfolio · 2021-03-31 ↗SEC reported portfolio · 2020-12-31 ↗summary prospectus · SEC 497K ↗SEC reported portfolio · 2020-09-30 ↗SEC reported portfolio · 2020-06-30 ↗summary prospectus · SEC 497K ↗SEC reported portfolio · 2020-03-31 ↗summary prospectus · SEC 497K ↗SEC reported portfolio · 2019-12-31 ↗summary prospectus · SEC 497K ↗SEC reported portfolio · 2019-09-30 ↗summary prospectus · SEC 497K ↗summary prospectus · SEC 497K ↗summary prospectus · SEC 497K ↗summary prospectus · SEC 497K ↗summary prospectus · SEC 497K ↗
Trading & Liquidity
Net asset value$184.59
Premium / discount[…]
Median spread · 30D[…]
Volume today11.3M
Average volume · 30D9.3M
Shares outstanding[…]
Options[…]
Fees & Costs
Net expense ratio0.08%
Gross expense ratio[…]
Management fee[…]
Cost on $10,000 a year$8.00
Our risk indicator4/5
Estimated yearly cost excludes trading costs and assumes constant assets.
Distributions
| Ex-date | Paid | Per share |
|---|---|---|
| Sep 21, 2026 | Sep 23, 2026 | $0.64 |
| Jun 22, 2026 | Jun 24, 2026 | $0.66 |
| Mar 23, 2026 | Mar 25, 2026 | $0.59 |
| Dec 22, 2025 | Dec 24, 2025 | $0.66 |
| Sep 22, 2025 | Sep 24, 2025 | $0.62 |
| Jun 23, 2025 | Jun 25, 2025 | $0.63 |
| Mar 24, 2025 | Mar 26, 2025 | $0.56 |
| Dec 23, 2024 | Dec 26, 2024 | $0.62 |
| Sep 23, 2024 | Sep 25, 2024 | $0.58 |
| Jun 24, 2024 | Jun 26, 2024 | $0.57 |
| Mar 18, 2024 | Mar 21, 2024 | $0.52 |
| Dec 18, 2023 | Dec 21, 2023 | $0.60 |
Issuer contentFrom SPDRHear the strategy from the people behind XLV.No issuer videos have been published for this fund.Are you the issuer? Claim this fund →